Jinhai Medical Technology Limited (Stock Code: 2225) has released an updated list of its board of directors and the composition of its board committees, effective 29 January 2026. According to the announcement, the board now comprises three executive directors—Chairman Mr. Chen Guobao, Chief Executive Officer Mr. Wang Zhenfei, and Mr. Li Yunping—alongside one non-executive director, Mr. Wang Huasheng, and three independent non-executive directors, Mr. Yan Jianjun, Mr. Fan Yimin, and Ms. Yang Meihua.

In terms of board committees, the new structure assigns Mr. Yan Jianjun as Chairman of the Audit and Remuneration Committees and Mr. Chen Guobao as Chairman of the Nomination Committee. The remaining directors serve as members of these committees, reflecting the company’s commitment to maintaining transparent and well-structured governance. The announcement notes that these changes are effective immediately.